Gene therapy of cancer (pages 167 to 173)

T. Mitrovi (Faculty of Sciences and Mathematics, Department of Biology and Ecology, Ni, Serbia and Montenegro), S. Radulovi

Adjuvant chemotherapy of breast cancer (pages 175 to 180)

S. Belija (Department of Medical Oncology, Institue of Oncology, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina)

Cancer cachexia and immunomodulation (pages 181 to 188)

P. M. Myrianthefs (Athens University School of Nursing, ICU at KAT Hospital, Athens, Greece), C. Batistaki

Colorectal cancer care in the Balkan countries (pages 189 to 193)

N. S. Turhal (University of Marmara, School of Medicine, Division of Oncology, Istanbul, Turkey), I. P. Popov

Germ cell testicular tumors in clinical stage A and normal values of serum tumor mark-ers post-orchiectomy the experience in the management of 300 consecutive patients (pages 195 to 200)

Dj. Argirovi (Clinic of Urology, Division of Urologic Chemotherapy, Clinical Center of Serbia, Beograd, Serbia and Montenegro)

VinorelbineVP-16 (etoposide) in metastatic breast cancer: a phase II study (pages 201 to 204)

G. Fried (Northern Israel Oncology Center, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel), M. E. Stein, A. Kuten, M. Quigley, A. Gershuny, N. Siegelmann-Danieli, J. Zaidan, N. Haim

5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event a prospective study (pages 205 to 211)

N. Tsavaris (Department of Pathophysiology, Oncology Unit, University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece), C. Kosmas, M. Vadiaka, E. Skopelitis, P. Kopteridis, S. Pamouki, M. Efremidis, H. Kasparian, I. Moisakis, D. Sakelariou, C. Koufos

The results of concomitant and sequential chemoradiotherapy with cisplatin and etoposide in patients with locally advanced non-small cell lung cancer (pages 213 to 218)

M. Saynak (Radiotherapy Department, Selcuk University, Meram Faculty of Medicine, Konya, Turkey), G. Aksu, M. Fayda, E. Kaytan, E. Oral, S. Gurocak, A. Kizir, A. Karadeniz

Prostate brachytherapy a three-year experience from the first 116 patients in Greece (pages 219 to 222)

A. Rempelakos (Department of Urology, 2Department of Radiation Oncology, Saint Savas Anticancer Institute, Athens, Greece), J. Katsilieris, R. Apatsidis, A. Roupakia, A. Palatzas, A. Thanos

Microsurgical spinothalamic chordotomy in the treatment of cancer pain (pages 223 to 226)

E. Slavik (Institute of Neurosurgery, Beograd, Serbia and Montenegro), S. Ivanovi, D. Grujii, B. Djurovi, I. Nikoli

A preclinical survey on the efficacy of lactandrate in the treatment of colon carcinoma (pages 227 to 234)

D. T.P. Trafalis (1st Department of Medical Oncology, Metaxa Cancer Hospital, Piraeus, Greece), G. D. Geromichalos, N. Bountouroglou, D. Koumbi, M. Kontos, D. Sougias, P. Dalezis, P. Karamanakos, A. Papageorgiou, C. Camoutsis, A. E. Athanassiou

Synergistic interaction between a novel mixed ligand copper(II) chelate complex and a panel of anticancer agents in T47D human breast cancer cells in vitro (pages 235 to 240)

G. D. Geromichalos (Symeonidio Research Center, Theagenio Cancer Hospital, Thessaloniki, Greece), G. A. Katsoulos, D. T. Trafalis, C. C. Hadjikostas, A. Papageorgiou

Radioligand binding assay determination of epidermal growth factor receptor in ovarian tumours (pages 241 to 246)

S. Tomov (Clinic of Gynecologic Oncology, Oncologic Center, Medical University, Pleven, Bulgaria), D. Tzingilev, G. Gorchev, A. Velkova, T. Vesselinova, S. Popovska

Sialylation and fucosylation of cancer-associated prostate specific antigen (pages 247 to 250)

M. M. Kosanovi (Institute for the Application of Nuclear Energy – INEP, Beograd, Serbia and Montenegro), M. M. Jankovi

Cytological grading of breast carcinoma with histological correlation (pages 251 to 256)

M. Jovici Milentijevi (Institute of Pathology, Cytopathology Unit, Medical School, University of Nis, Nis, Serbia and Montenegro), R. Ili, I. Milentijevi

Oxidative stress in blood in cases of untreated refractory anaemia (pages 257 to 260)

N.. Tzvetkov (Clinic of Haematology, Medical University, Pleven, Bulgaria), P. Bochev, M. Alexandrova

Lymphocyte subsets in peripheral blood as prognostic factors in colorectal cancer (pages 261 to 264)

V. Milasiene (Laboratory of Experimental Oncology, Institute of Oncology, Vilnius University, Vilnius, Lithuania), E. Stratilatovas, V. Norkiene, R. Jonusauskaite

Diagnosis of prostate cancer in Serbia (pages 265 to 269)

V. Vukoti-Maleti (Thermotherapy Center, Beograd, Serbia and Montenegro), S. Cerovi, M. Lazi, I. Rakovi

Invasive micropapillary carcinoma of breast case report with literature review (pages 271 to 275)

N. K. De Silva (Cambridge Breast Unit, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK), S. Pinder, A. D. Purushotham

Acute abdomen as initial manifestation of M4 – acute non-lymphocytic leukemia (pages 277 to 280)

E. Papalambros (First Department of Surgery, Laikon General University Hospital, University of Athens, Medical School, Athens, Greece), E. Felekouras, I. G. Karavokyros, T. Diamantis, A. Androulaki, D. Boutsis, F. Sigala, N. Tsavaris, G. Pangalis

Epidural metastasis of Ewing’s sarcoma a rare localisation (pages 281 to 284)

F. O. Dincbas (Department of Radiation Oncology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey), D. C. Oksuz, B. Atalar, S. Dervisolu, N. Kocer, N. M. Mandel, S. Koca

Anne of Austria (1601-1666), queen of France died of breast cancer (pages 285 to 289)

G. Androutsos (Institute of History of Medicine, University Claude Bernard, Lyon, France)